Mass spectrometric characterisation of the circulating peptidome following oral glucose ingestion in control and gastrectomised patients.
R. G. Kay, R. E. Foreman, G. P. Roberts, R. Hardwick, F. Reimann, F. M. Gribble
Abstract
Meal ingestion triggers secretion of a variety of gut and endocrine peptides, several of which are routinely measured in research studies by commercial immunoassays. We developed an LC-MS/MS based assay for parallel monitoring of multiple peptides in small volumes of human plasma, providing the benefit of analysing exact peptide sequences rather than immuno-reactivity, and potential advantages of cost and sample volumes for measuring multiple peptide hormones. The method involves acetonitrile precipitation of larger proteins, followed by solid phase extraction and nano-LC-MS/MS using an untargeted approach on an orbitrap mass spectrometer. Analysis of plasma from control subjects and patients who have undergone gastrectomy with Roux-en-Y reconstruction, revealed elevated levels of a number of peptides following glucose ingestion. These included GLP-1(7-36), GLP-1(9-36), glicentin, oxyntomodulin, GIP(1-42), GIP(3-42), PYY(1-36), PYY(3-36), neurotensin, insulin and C-peptide, as well as motilin, which decreased following glucose ingestion. Results showed good correlation with those peptides measured previously by immunoassay in the same samples. The gastrectomy group had higher, but non-glucose-dependent, circulating levels of peptides from PIGR and DMBT1. Overall, the method is fast, generic, reproducible and inexpensive, and requires only small plasma samples, making it potentially adaptable for multiplexed measurement of a variety of peptides.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of dipeptidyl peptidase 4 allows accurate measurement of GLP-1 secretion in mice
M. M. Smits, K. D. Galsgaard, … J. J. Holst·bioRxiv·Oct 19, 2023
- In-vitro Metabolite Identification for MEDI7219, an Oral GLP-1 Peptide, using LC-MS/MS with CID and EAD Fragmentation
Kate Liu, Yue Huang, … Anton I. Rosenbaum·BioanalysisPeer-reviewed·Jul 3, 2025
- CHANGES OF TLQP-21 IN RESPONSE TO GLUCOSE LOAD
C. Cocco, G. Corda, … G.-L. Ferri·bioRxiv·May 2, 2019
- Peptide-based GIP receptor inhibition produces limited metabolic improvements in mice whether alone or combined with GLP-1 agonism.
Jason A. West, Soumitra S. Ghosh, … Gavin A. Bewick·bioRxiv·Oct 29, 2019
- Secretin release after Roux-en-Y Gastric Bypass reveals a population of glucose-sensitive S-cells in distal small intestine
I. M. Modvig, D. B. Andersen, … J. J. Holst·International Journal of ObesityPeer-reviewed·Feb 3, 2020
- Novel mediation analysis of human plasma proteome and metabolome reveals mediators of improved glycemia after gastric bypass surgery
Jonathan M. Dreyfuss, Yixing Yuchi, … Mary‐Elizabeth Patti·Nature CommunicationsPeer-reviewed·Nov 29, 2021